Bois-Colombes, June 08, 2017 - The subsidiary Chiesi France, chaired by Mr Patrice Carayon, officially opened its new offices at 17 avenue de l'Europe in Bois Colombes.
140 people attended at the event, including the Italian leaders: Dr Alberto Chiesi - President, Mr Ugo Di Francesco - CEO and Mr Alessandro Chiesi.
Also present were the headquarters including R & D, part of the Factory of the Chaussée Saint Victor (41) and some people representing the ground teams in France. This reinforces the particularity of Chiesi France, the only foreign family laboratory present in France throughout the value chain; From research and development, through production and distribution to the provision of patients.
These new modern workspaces inaugurated reinforce the transversality of the teams of the French subsidiary (Management, R & D, operational and administrative teams) expressing true corporate values to which the Chiesi Group is attached:
•respect for employees
Chiesi, sensitive to the welfare of its employees, has promoted, within an environment-friendly site, the development of a new, airy, modern work environment inviting exchange and proximity.
About the Chiesi Group
Headquartered in Parma, Italy, Chiesi Farmaceutici is an international research-oriented laboratory with more than 80 years of experience in the pharmaceutical industry and present in 26 countries. Chiesi studies, develops and markets innovative medicines in the therapeutic fields of respiratory, specialized medicine and rare diseases. Its R & D center, based in Parma (Italy), is integrated with 6 other R & D groups in France, the United States, the United Kingdom, Sweden and Denmark to develop preclinical, clinical and registration programs. Chiesi employs over 5,000 people. For more information, visit our website at www.chiesi.fr